Skip to content

Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777420Recalls & reported problems

C. R. Bard, Inc. · INLAY URETERAL STENT W/HYDROGLIDE GUIDEWIRE · Class 2 · Implant

All models of Bard InLay Ureteral Stent with HydroGlide Guidewire (17)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10801741014458), received between Nov 3, 2021 and Nov 3, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Biocompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Biocompatibility1
  • Patient Device Interaction Problem1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Discomfort1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 3, 2021Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem

    IT WAS REPORTED THAT THE PATIENT EXPERIENCED PAIN, DISCOMFORT AND URINARY SYMPTOMS WHILE USING THE BARD URETERAL STENT. IT WAS UNKNOWN WHAT MEDICAL INTERVENTION WAS PROVIDED.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Discomfort; Pain

    MAUDE report 12745810 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page